Our data showed that anti-CD169 Ab-Ag conjugate and ganglioside-liposomes were efficiently taken up by CD169+ monocytes and delivered tumor-associated antigens which led to robust antigen-specific CD8+ T cell responses. Here, SIGLEC1 is linked to neoplasm.